Speaker: Helena Geys, Janssen Pharmaceutica and Philip Jarvis, AstraZeneca
An assessment of the statistical methods used to analyse toxicology studies
Co-authors: Jim Saul, Mike Aylott, Simon Bate and John Sherington;
Pharmaceutical Statistics, Volume 10, Issue 6, Pages 477-484, November/December 2011 Abstract | Paper+ | Slides
Speaker: Martin Jenkins, AstraZeneca and Chris Harbron, AstraZeneca
A statistician's perspective on biomarkers in drug development
Co-authors: Aiden Flynn, Trevor Smart, Tony Sabin, Jayantha Ratnayake, Paul Delmar, Athula Herath, Philip Jarvis and James Matcham;
Pharmaceutical Statistics, Volume 10, Issue 6, Pages 494-507, November/December 2011 Abstract | Paper+ | Slides
+ Papers available to view from 20th September 2012 to 18th October 2012.
For a flier advertising the event, please click here.
Joint PSI, EFSPI & ASA BIOP Webinar: Estimands
PSI, the European Federation of Statisticians in the Pharmaceutical Industry (EFSPI) and the Biopharmaceutical Section of the American Statistical Association (ASA) are jointly organising a webinar on Estimands in Practice. Speakers from regulatory authorities (FDA and EMA) and industry will present on their experience on this topic to date.
Discover your potential by working as a Covance Senior Principal / Principal Biostatistician. You'll enjoy a varied role working for different sponsors across several therapeutic areas, leading projects and mentoring junior members of the department.
Biometrics at AstraZeneca provides the data that influences decisions on how we roll back the frontiers of science to bring life-changing medicines to the world. We are at the heart of design, analytics and interpretation of AstraZeneca’s portfolio.